Stay updated on NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Sign up to get notified when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.

Latest updates to the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page
- Check5 days agoChange DetectedRemoved the page-wide government funding lapse notice that previously appeared on the page. Core study details, eligibility criteria, and related content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA Results section has been added with updated outcome measures. The Study Record Dates reflect the latest status, including Results First Posted 2025-04-04.SummaryDifference0.5%

- Check48 days agoChange DetectedIntroducing a government funding status notice and a new version tag (v3.2.0) with removal of the previous version (v3.1.0).SummaryDifference3%

- Check55 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.1%

- Check70 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' link.SummaryDifference0.2%

- Check77 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

Stay in the know with updates to NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer
Enter your email address, and we'll notify you when there's something new on the NEOMUN Trial: Anti-PD-1 in Resectable Lung Cancer page.